Methylprednisone
Sponsors
Genentech, Inc., Dana-Farber Cancer Institute, M.D. Anderson Cancer Center, Astellas Pharma Global Development, Inc., St. Petersburg State Pavlov Medical University
Conditions
Acute Lymphoblastic LeukemiaAcute Lymphocytic LeukemiaCardiogenic ShockHealthy VolunteersHeart FailureInflammationIntestinal GVHDKidney Transplantation
Phase 1
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia
CompletedNCT00968253
Start: 2009-11-30End: 2015-12-31Updated: 2019-02-27
Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD
TerminatedNCT04269850
Start: 2019-09-01End: 2024-11-27Updated: 2024-12-03
Study of the Excretion of Orally Administered Corticosteroids for the Improval of the Detection of Said Substances in Anti-doping Controls
NCT04791345
Start: 2021-02-26End: 2022-02-26Target: 50Updated: 2021-04-01
Phase 2
A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
CompletedNCT00282308
Start: 2006-01-23End: 2012-05-28Updated: 2017-08-10
ALL Adult Consortium Trial: Adult ALL Trial
CompletedNCT00476190
Start: 2007-04-30End: 2020-03-31Updated: 2025-06-12
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
CompletedNCT01780844
Start: 2013-03-05End: 2017-01-27Updated: 2025-11-21
Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients
CompletedNCT02921789
Start: 2017-05-22End: 2021-05-18Updated: 2024-12-04
CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock
Not yet recruitingNCT07461961
Start: 2026-07-01End: 2029-02-01Target: 30Updated: 2026-03-10